Skip to content

Palvella Therapeutics PVLA Market capitalization

Market capitalization at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.78B+300%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2B+82.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$1.72B+18.3%
Precigen logo
PrecigenPGEN
$1.37B+213%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$2.92B+57.5%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$2.33B+1,477%

Other financials

Income statement

See full
Revenue$53.0K-97.3%
Operating income-$14.9M-88.7%
Net income-$15.8M-92.6%
EPS (diluted)-$1.20-62.2%

Balance sheet

See full
Cash & equivalents$206.4M+173%
Total debt$584.0K
Total equity$232.3M+318%
Total assets$263.8M+232%

Cash flow

See full
Operating cash flow-$10.9M-60.5%
CapEx--100%
Free cash flow-$2.7M+72.0%

Valuation

See full
Enterprise value$1.5B
P/S41.6×

Profitability

See full
Operating margin-183.2%-13.5pp
Net margin71.7%+40.4pp
FCF margin-99.8%-34.2pp

Returns & leverage

See full
Return on equity-34.2%
Debt / equity
Current ratio28.9×+20.0×

Where this comes from

Computed from the period-end share price: $1.78B.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Palvella Therapeutics's market capitalization?
Palvella Therapeutics (PVLA) reported market capitalization of $1.78B in Q1 2026.
How has Palvella Therapeutics's market capitalization changed year-over-year?
Palvella Therapeutics's market capitalization increased by 468.1% year-over-year, from $314.08M to $1.78B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.